PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A meta-analysis of clinical and preclinical trials showed a statistically significant decrease in serum glucose and glycosylated hemoglobin (HbA1c) after three months [PMID:40941053].
Supplementation in older adults significantly decreased lipoperoxides, protein carbonylation, 8-OHdG, and total oxidant status (TOS), while increasing total antioxidant status (TAS) [PMID:37140004, PMID:37836390].
Consumption of Sechium edule was associated with the prevention of telomere attrition in older adults with metabolic syndrome [PMID:37140004].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30724233 (2019) — Chayote (Sechium edule): A review of nutritional composition, bioactivities and potential applications. · Food chemistry
- 2.PMID: 38285143 (2024) — Micropropagation of Chayote (Sechium edule L.) var. virens levis in RITA®. · Methods in molecular biology (Clifton, N.J.)
- 3.PMID: 39124250 (2024) — Evaluation of the Antigenotoxic Potential of Two Types of Chayote (Sechium edule) Juices. · Plants (Basel, Switzerland)
- 4.PMID: 31174790 (2019) — New insight into phenolic composition of chayote (Sechium edule (Jacq.) Sw.). · Food chemistry
- 5.PMID: 34630492 (2021) — Origin, Evolution, Breeding, and Omics of Chayote, an Important Cucurbitaceae Vegetable Crop.